Epic Update : Ranbaxy Laboratories

Ranbaxy Laboratories has received approval from the Central Drugs Standard Control Organisation (CDSCO), Government of India to manufacture and market Synriam (arterolane maleate and piperaquine phosphate tablet 150+750 mg) in India for the treatment of uncomplicated malaria in adults caused by Plasmodium vivax parasite.

http://www.epicresearch.co/

0731-664-2300